Rare Neurodegenerative Disease Grants Program

Clinical Trials Grants Program is sponsored by FDA (Office of Orphan Products Development - OOPD). This program funds clinical trials evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions. It encourages innovative and efficient clinical trial methods.

Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required is sponsored by U.S. Food and Drug Administration (FDA) - Rare Neurodegenerative Disease Grants Program. This funding opportunity supports clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare neurodegenerative diseases for children and adults.